what reality check? AMBS despite this recent drop.. is still up over 100% since DEC 13 .....you do know that NUV____ is in the middle of a major paid promo pump that coincided with that news
you should post about that stock on that Board not this one.. IMO
Move Over Celgene Here Comes Nuvilex and $27 Million to Advance Its Pancreatic Cancer Clinical Trials
NEW YORK, NY--(Marketwired - Feb 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) just became relevant in the biotech industry. The company can now move forward with its clinical trials for the treatment of advanced inoperable pancreatic cancer after Nuvilex landed a $27 million funding deal that could change the sector for years to come. Funding is always the biggest hurdle for any small biotechnology or pharmaceutical firm, and its why larger firms with competing treatments can often sit back without worry of new competition.
But, as many biotech investors know, it only takes one believer with deep pockets to come along and fund a firm's clinical trials. It is then that big pharma becomes a bit more aware of their new competitor's future. Nuvilex has found that believer, and it's in the form of an institutional investor that will dedicate at least $27 million towards Nuvilex's future and its Cell-in-a-Box based pancreatic cancer treatment.
Now that is a huge funding deal! Would be great to wake up to similar news " AMARANTUS Bioscience announces $20 million funding "
The past few days have been tough to digest. It is never fun watching profits disappear.
But lets not forget, up-listing to a national exchange should bring in the institutional investors plus we'll be out of MM manipulation range. I am trying not to lose my head with possible reverse split scenarios.
I think once the IND enabling studies are completed and we have a timeline for the first IND application this stock will be well beyond the current pps range soon after.
Lets hope this upcoming blog next week doesn't drop us some more like usual.
News 
Market Data 
Discover 
